Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Elarofiban TFA (RWJ-53308 TFA) is a novel and orally active and selective GPIIb/IIIa antagonist for the study of cardiovascular disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 195.00 | |
5 mg | In stock | $ 483.00 | |
10 mg | In stock | $ 692.00 | |
25 mg | In stock | $ 1,080.00 | |
50 mg | In stock | $ 1,490.00 | |
100 mg | In stock | $ 1,970.00 |
Description | Elarofiban TFA (RWJ-53308 TFA) is a novel and orally active and selective GPIIb/IIIa antagonist for the study of cardiovascular disease. |
Synonyms | Elarofiban TFA(198958-88-2 Free base), RWJ-53308 TFA |
Molecular Weight | 644.56 |
Formula | C26H34F6N4O8 |
CAS No. | 198958-89-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Elarofiban TFA 198958-89-3 Cytoskeletal Signaling Integrin Elarofiban TFA(198958-88-2 Free base) RWJ-53308 TFA inhibitor inhibit